Arthur J. Gallagher & Co. (AJG) Analyst Forecast
Revenue and earnings estimates published by analysts covering Arthur J. Gallagher & Co. (AJG), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.
For Arthur J. Gallagher & Co., analysts forecast revenue rising from $10001.77T in 2023 to $19544.23T in 2028; the average estimate for 2028 earnings per share is $16.66; with published estimates ranging from $14.15 to $18.41; 15 analysts contribute to these figures. These are forecasts published by analysts, not results.
Analyst price targets
A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.
Revenue forecast (USD millions)
The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.
Earnings per share forecast
Arthur J. Gallagher & Co. (AJG) forecast — frequently asked questions
What is the analyst price target for Arthur J. Gallagher & Co.?
Analysts covering Arthur J. Gallagher & Co. (AJG) have a consensus price target of $278.45, 5.3% above the current price of $264.46. Published targets range from $225.00 to $300.00. A price target is a forecast, not a measure of value, and targets are revised often.
What are analysts forecasting for Arthur J. Gallagher & Co.'s earnings?
The average analyst estimate for Arthur J. Gallagher & Co. (AJG) earnings per share in 2028 is 16.66, with individual estimates between 14.15 and 18.41.
How much revenue is Arthur J. Gallagher & Co. expected to make?
Analysts forecast Arthur J. Gallagher & Co. (AJG) revenue of $19544.23T in 2028, based on 5 published estimates.
How many analysts cover AJG?
15 analysts contribute estimates for Arthur J. Gallagher & Co. (AJG). Thin coverage makes an average less reliable.
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.